173 related articles for article (PubMed ID: 29424802)
1. Predictors of Topiramate Tolerability in Heavy Cannabis-Using Adolescents and Young Adults: A Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial.
Gray JC; Treloar Padovano H; Wemm SE; Miranda R
J Clin Psychopharmacol; 2018 Apr; 38(2):134-137. PubMed ID: 29424802
[TBL] [Abstract][Full Text] [Related]
2. Topiramate and motivational enhancement therapy for cannabis use among youth: a randomized placebo-controlled pilot study.
Miranda R; Treloar H; Blanchard A; Justus A; Monti PM; Chun T; Swift R; Tidey JW; Gwaltney CJ
Addict Biol; 2017 May; 22(3):779-790. PubMed ID: 26752416
[TBL] [Abstract][Full Text] [Related]
3. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of topiramate in the treatment of crack cocaine dependence: a double-blind, randomized, placebo-controlled trial.
Baldaçara L; Cogo-Moreira H; Parreira BL; Diniz TA; Milhomem JJ; Fernandes CC; Lacerda AL
J Clin Psychiatry; 2016 Mar; 77(3):398-406. PubMed ID: 27046312
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
[TBL] [Abstract][Full Text] [Related]
6. Topiramate for the treatment of cocaine addiction: a randomized clinical trial.
Johnson BA; Ait-Daoud N; Wang XQ; Penberthy JK; Javors MA; Seneviratne C; Liu L
JAMA Psychiatry; 2013 Dec; 70(12):1338-46. PubMed ID: 24132249
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder.
Lindley SE; Carlson EB; Hill K
J Clin Psychopharmacol; 2007 Dec; 27(6):677-81. PubMed ID: 18004136
[TBL] [Abstract][Full Text] [Related]
8. Topiramate in the long-term treatment of binge-eating disorder associated with obesity.
McElroy SL; Shapira NA; Arnold LM; Keck PE; Rosenthal NR; Wu SC; Capece JA; Fazzio L; Hudson JI
J Clin Psychiatry; 2004 Nov; 65(11):1463-9. PubMed ID: 15554757
[TBL] [Abstract][Full Text] [Related]
9. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group.
Privitera M; Fincham R; Penry J; Reife R; Kramer L; Pledger G; Karim R
Neurology; 1996 Jun; 46(6):1678-83. PubMed ID: 8649569
[TBL] [Abstract][Full Text] [Related]
10. Topiramate in migraine prevention: a double-blind, placebo-controlled study.
Storey JR; Calder CS; Hart DE; Potter DL
Headache; 2001; 41(10):968-75. PubMed ID: 11903524
[TBL] [Abstract][Full Text] [Related]
11. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.
Gray KM; Sonne SC; McClure EA; Ghitza UE; Matthews AG; McRae-Clark AL; Carroll KM; Potter JS; Wiest K; Mooney LJ; Hasson A; Walsh SL; Lofwall MR; Babalonis S; Lindblad RW; Sparenborg S; Wahle A; King JS; Baker NL; Tomko RL; Haynes LF; Vandrey RG; Levin FR
Drug Alcohol Depend; 2017 Aug; 177():249-257. PubMed ID: 28623823
[TBL] [Abstract][Full Text] [Related]
12. Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials.
Kushner SF; Khan A; Lane R; Olson WH
Bipolar Disord; 2006 Feb; 8(1):15-27. PubMed ID: 16411977
[TBL] [Abstract][Full Text] [Related]
13. Topiramate: a new antiepileptic drug.
Privitera MD
Ann Pharmacother; 1997 Oct; 31(10):1164-73. PubMed ID: 9337443
[TBL] [Abstract][Full Text] [Related]
14. Combined pharmacotherapy and evidence-based psychosocial Cannabis treatment for youth and selection of cannabis-using friends.
Meisel SN; Treloar Padovano H; Miranda R
Drug Alcohol Depend; 2021 Aug; 225():108747. PubMed ID: 34052685
[TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age.
Lewis D; Winner P; Saper J; Ness S; Polverejan E; Wang S; Kurland CL; Nye J; Yuen E; Eerdekens M; Ford L
Pediatrics; 2009 Mar; 123(3):924-34. PubMed ID: 19255022
[TBL] [Abstract][Full Text] [Related]
16. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
Winner P; Pearlman EM; Linder SL; Jordan DM; Fisher AC; Hulihan J;
Headache; 2005; 45(10):1304-12. PubMed ID: 16324162
[TBL] [Abstract][Full Text] [Related]
17. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures.
Hoopes SP; Reimherr FW; Hedges DW; Rosenthal NR; Kamin M; Karim R; Capece JA; Karvois D
J Clin Psychiatry; 2003 Nov; 64(11):1335-41. PubMed ID: 14658948
[TBL] [Abstract][Full Text] [Related]
18. A pooled analysis of adjunctive topiramate in refractory partial epilepsy.
Peeters K; Adriaenssen I; Wapenaar R; Neto W; Pledger G
Acta Neurol Scand; 2003 Jul; 108(1):9-15. PubMed ID: 12807387
[TBL] [Abstract][Full Text] [Related]
19. Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study.
McIntyre RS; Mancini DA; McCann S; Srinivasan J; Sagman D; Kennedy SH
Bipolar Disord; 2002 Jun; 4(3):207-13. PubMed ID: 12180276
[TBL] [Abstract][Full Text] [Related]
20. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group.
Faught E; Wilder BJ; Ramsay RE; Reife RA; Kramer LD; Pledger GW; Karim RM
Neurology; 1996 Jun; 46(6):1684-90. PubMed ID: 8649570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
